What one share of Vanda Pharmaceuticals holds
Vanda Pharmaceuticals Inc. (we, our, the Company or Vanda) is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
Vanda Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.63 |
|---|---|
| Profit | −$4.62 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$2.40 |
| Cash and investments | $0.92 |
| Book value | $3.64 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.17 | −$1.33 | — | — | — | $0.85 |
| 2010 | $1.25 | $0.25 | — | — | — | $1.35 |
| 2011 | $1.11 | −$0.35 | $0.01 | −$1.02 | — | $1.19 |
| 2012 | $1.16 | −$1.01 | $0.07 | −$1.66 | — | $0.35 |
| 2013 | $1.12 | −$0.69 | $0.01 | −$1.31 | — | $1.32 |
| 2014 | $1.37 | $0.55 | $0.02 | −$2.24 | — | $3.88 |
| 2015 | $2.60 | −$0.94 | $0.06 | $0.23 | — | $3.11 |
| 2016 | $3.36 | −$0.41 | $0.03 | −$0.22 | — | $2.98 |
| 2017 | $3.69 | −$0.35 | $0.04 | −$0.08 | — | $2.92 |
| 2018 | $3.64 | $0.48 | $0.01 | $0.56 | — | $5.25 |
| 2019 | $4.14 | $2.11 | $0.02 | $0.82 | — | $7.67 |
| 2020 | $4.50 | $0.42 | $0.03 | $0.91 | — | $8.26 |
| 2021 | $4.72 | $0.58 | $0.01 | $1.12 | — | $9.03 |
| 2022 | $4.46 | $0.11 | $0.01 | $0.55 | — | $9.28 |
| 2023 | $3.35 | $0.04 | $0.01 | $0.22 | — | $9.47 |
| 2024 | $3.42 | −$0.33 | $0.01 | −$0.28 | — | $9.24 |
| 2025 | $3.67 | −$3.74 | $0.02 | −$1.87 | — | $5.54 |
Common questions about Vanda Pharmaceuticals
How much does one share of Vanda Pharmaceuticals earn?
Over the last 12 months, Vanda Pharmaceuticals lost $4.62 for each share on $3.63 of sales.
Does Vanda Pharmaceuticals pay a dividend?
Vanda Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Vanda Pharmaceuticals’s book value per share?
Vanda Pharmaceuticals’s book value is $3.64 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Vanda Pharmaceuticals have?
Each share of Vanda Pharmaceuticals has $0.92 of cash and investments, as of June 30, 2026.
What is Vanda Pharmaceuticals’s free cash flow per share?
−$2.40 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Vanda Pharmaceuticals bought back shares?
Vanda Pharmaceuticals’s share count rose about 118% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.